Assays to enable interrogation of the MOA of GLP-1, GIP, and GCG receptors targeting therapeutics to accelerate obesity and type-2 diabetes drug devel...Show More
Cell-based assays to accelerate COVID-19 drug discovery from basic research through QC lot release programs focused on managing proinflammatory cytoki...Show More